Regulus Therapeutics Inc.
RGLS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Income
Balance Sheet
Cash Flow
RGLS Income Statement
RGLS Balance Sheet
RGLS Cash Flow
Recent trades of RGLS by members of U.S. Congress
RGLS Stock Insider Trading Activity
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
RGLS Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
RGLS Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by RGLS's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
U.S. Patents
New patents grants
-
Patent Title: Galnac conjugated modified oligonucleotides as mir-122 inhibitor having hcv antiviral activity with reduced hyperbilirubinemia side-effect Jun. 11, 2024
-
Patent Title: Methods for treatment of polycystic kidney disease Nov. 09, 2021
-
Patent Title: Compounds and methods for enhanced cellular uptake Mar. 09, 2021
-
Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Mar. 10, 2020
-
Patent Title: Targeting micrornas for the treatment of liver cancer May. 28, 2019
-
Patent Title: Compounds and methods for enhanced cellular uptake Mar. 26, 2019
-
Patent Title: Microrna compounds and methods for modulating mir-122 Dec. 11, 2018
-
Patent Title: Targeting micrornas for metabolic disorders Nov. 27, 2018
-
Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Oct. 09, 2018
-
Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Sep. 11, 2018
-
Patent Title: Microrna compounds and methods for modulating mir-21 activity Jun. 12, 2018
-
Patent Title: Methods for use in modulating mir-122a Jun. 12, 2018
-
Patent Title: Methods for treatment of alport syndrome May. 15, 2018
-
Patent Title: Microrna compounds and methods for modulating mir-21 activity May. 15, 2018
-
Patent Title: Targeting micrornas for the treatment of fibrosis May. 15, 2018
-
Patent Title: Targeting micrornas for metabolic disorders Jan. 09, 2018
-
Patent Title: Targeting micrornas for the treatment of liver cancer Dec. 19, 2017
-
Patent Title: Microrna compounds and methods for modulating mir-21 activity Oct. 17, 2017
-
Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Sep. 05, 2017
-
Patent Title: Methods for treatment of alport syndrome Jun. 27, 2017
-
Patent Title: Microrna compounds and methods for modulating mir-21 activity Jun. 27, 2017
-
Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas May. 30, 2017
-
Patent Title: Microrna compounds and methods for modulating mir-122 Feb. 21, 2017
-
Patent Title: Targeting micrornas for the treatment of fibrosis Jan. 31, 2017
-
Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Dec. 27, 2016
-
Patent Title: Targeting micrornas for the treatment of liver cancer Nov. 29, 2016
-
Patent Title: Compounds and methods for enhanced cellular uptake Nov. 29, 2016
-
Patent Title: Targeting micrornas for metabolic disorders Nov. 08, 2016
-
Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Sep. 20, 2016
-
Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Sep. 20, 2016
-
Patent Title: Methods for treatment of alport syndrome Jun. 07, 2016
-
Patent Title: Microrna compounds and methods for modulating mir-122 Apr. 12, 2016
-
Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Feb. 23, 2016
-
Patent Title: Microrna compounds and methods for modulating mir-21 activity Feb. 23, 2016
-
Patent Title: Targeting micrornas for the treatment of fibrosis Nov. 10, 2015
-
Patent Title: Microrna compounds and methods for modulating mir-21 activity Nov. 10, 2015
-
Patent Title: Microrna compounds and methods for modulating mir-122 Oct. 13, 2015
-
Patent Title: Targeting micrornas for the treatment of liver cancer Oct. 06, 2015
-
Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Sep. 22, 2015
-
Patent Title: Methods for treatment of alport syndrome Apr. 21, 2015
-
Patent Title: Microrna compounds and methods for modulating mir-21 activity Mar. 03, 2015
-
Patent Title: Methods for use in modulating mir-122a Mar. 03, 2015
-
Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Feb. 03, 2015
-
Patent Title: Microrna compounds and methods for modulating mir-21 activity Dec. 16, 2014
-
Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Oct. 14, 2014
-
Patent Title: Microrna compositions and methods Sep. 30, 2014
-
Patent Title: Targeting micrornas for the treatment of fibrosis Aug. 26, 2014
-
Patent Title: Method of inhibiting mir-33 using a modified oligonucleotide Aug. 19, 2014
-
Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Jul. 01, 2014
-
Patent Title: Oligomeric compounds and compositions for use in modulation of small non-coding rnas Apr. 15, 2014
Government Contracts
Federal grants, loans, and purchases
Government Contracts
Estimated quarterly amount awarded from public contracts
WallStreetBets
Number of mentions of RGLS in WallStreetBets Daily Discussion
RGLS News
Recent insights relating to RGLS
CNBC Recommendations
Recent picks made for RGLS stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in RGLS
RGLS Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view RGLS Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More